Incidence and outcomes of cardiovascular implantable electronic device infections in patients with end-stage kidney disease
Open Access
- 13 September 2024
- journal article
- Published by Elsevier in Heart Rhythm
- Vol. 22 (3) , 744-751
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 14 references indexed in Scilit:
- Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model familyEP Europace, 2023
- Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patientsHeart Rhythm, 2021
- Risk Factors for Infections Involving Cardiac Implanted Electronic DevicesJACC, 2019
- Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018)European Heart Journal, 2019
- Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta‐analysisJournal of Cardiovascular Electrophysiology, 2019
- Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal diseaseEP Europace, 2017
- Cardiac implantable electronic device infection in patients with end-stage renal diseaseHeart Rhythm, 2015
- Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysisEP Europace, 2015
- Clinical Presentation and Outcomes of Cardiovascular Implantable Electronic Device Infections in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2014
- Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patientsAmerican Journal of Infection Control, 2004